Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 25 | 0 | 7,562 | 91 | 1,096 |
| Gross Profit | 25 | 0 | 7,562 | 91 | 1,096 |
| Operating Expenses | 2,547 | 2,239 | 2,488 | 1,941 | 1,865 |
| Operating Income | -2,522 | -2,239 | 5,074 | -1,850 | -769 |
| Interest Expense | 1 | 0 | 0 | 4 | 10 |
| Other Income | 109 | 108 | 180 | 110 | 142 |
| Pre-tax Income | -2,414 | -2,131 | 5,254 | -1,743 | -638 |
| Income Tax | N/A | N/A | 100 | N/A | 100 |
| Net Income Continuous | -2,414 | -2,131 | 5,154 | -1,743 | -738 |
| Net Income | $-2,414 | $-2,131 | $5,154 | $-1,743 | $-738 |
| EPS Basic Total Ops | -7,123.02 | -6,331.57 | 18,598.98 | -7,123.02 | -3,165.78 |
| EPS Basic Continuous Ops | -7,201.06 | -6,036.17 | 18,549.04 | -7,255.88 | -3,171.54 |
| EPS Diluted Total Ops | -7,123.02 | -5,540.12 | 17,807.54 | -7,123.02 | -3,165.78 |
| EPS Diluted Continuous Ops | -7,201.06 | -5,389.27 | 17,758.70 | -7,255.88 | -3,171.54 |
| EBITDA(a) | $-2,356 | $-2,172 | $5,099 | $-1,758 | $-697 |